Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell-Derived NK Cell Therapies.
Saved in:
| Title: | Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell-Derived NK Cell Therapies. |
|---|---|
| Authors: | Chen Q; State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China., Lv J; School of Life Sciences, Xiamen University, Xiamen, China., Xie X; School of Life Science, Beijing Institute of Technology, Beijing, China., Zhu H; School of Life Science, Beijing Institute of Technology, Beijing, China., Xiao Z; School of Life Science, Beijing Institute of Technology, Beijing, China., Peng Y; State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China.; University of the Chinese Academy of Sciences, Beijing, China. |
| Source: | Cell proliferation [Cell Prolif] 2026 Apr; Vol. 59 (4), pp. e70129. Date of Electronic Publication: 2025 Sep 29. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Published for the Cell Kinetics Society, the European Study Group for Cell Proliferation, and the International Cell Cycle Society by Blackwell Scientific Publications Country of Publication: England NLM ID: 9105195 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2184 (Electronic) Linking ISSN: 09607722 NLM ISO Abbreviation: Cell Prolif Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
